|
Research Management and Support
|
RMS2011 [E]
|
$335,240,650
|
$38,000
|
N/A
|
National Cancer Institute
|
|
Development of personalized surgical algorithms for muscle-invasive bladder cancer patients
|
5R21CA218976-02
|
$238,815
|
|
ABBOSH, PHILIP
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Detection of somatic, subclonal and mosaic CNVs from sequencing
|
1U24CA220242-01A1
|
$559,916
|
|
ABYZOV, ALEXEJ
|
MAYO CLINIC ROCHESTER
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
COG NCTN Network Group Operations Center
|
5U10CA180886-05
|
$20,853,800
|
$2,919,532
|
ADAMSON, PETER
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
5R01CA140368-07
|
$369,313
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Targeting SHP2 as a precision medicine for the treatment of HER2-positive breast cancer
|
1R01CA213996-01A1
|
$343,125
|
|
AGAZIE, YEHENEW
|
WEST VIRGINIA UNIVERSITY
|
|
Analysis of HCC CTC Phenotype for Liver Transplant Candidate Selection
|
1R21CA216807-01A1
|
$203,254
|
|
AGOPIAN, VATCHE
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Functional Determinants of Metastatic Dormancy
|
5R01CA109182-15
|
$423,844
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Epigenetic and microenvironmental regulation of dormant disseminated cancer
|
5R01CA218024-02
|
$428,136
|
|
AGUIRRE-GHISO, JULIO
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Assessment of sensory gating, attention, and executive control in breast cancer
|
1R01CA218496-01A1
|
$687,576
|
|
AHLES, TIM
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
|
5R01CA134633-06
|
$535,071
|
|
AHRENS, ERIC
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mapping cancer micro-environments for acute leukemia
|
5R01CA202025-03
|
$455,870
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Post-translational control of cancer cell stress response and metastasis
|
5R01CA202027-03
|
$459,505
|
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Lymphatic and systemic immunity changes in post-radiation lymphedema development
|
5R01CA201487-03
|
$357,343
|
|
ALDRICH, MELISSA
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
Targeting transducin Beta-like protein 1 in mantle cell lymphoma
|
1K08CA226352-01
|
$227,046
|
|
ALINARI, LAPO
|
OHIO STATE UNIVERSITY
|
|
Hyperbaric oxygen to improve blood count recovery in Auto-HCT for myeloma
|
1R37CA225791-01
|
$358,389
|
|
ALJITAWI, OMAR
|
UNIVERSITY OF ROCHESTER
|
|
Single-Cell Measurement of Lipid Signaling in Colorectal Cancer
|
5R01CA177993-05
|
$575,397
|
|
ALLBRITTON, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
$435,560
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
The Role of LSD1 in the Evolution of Castration Resistant Prostate Cancer
|
5R01CA178610-05
|
$317,240
|
|
ALUMKAL, JOSHI
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
5R01CA208042-03
|
$363,713
|
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
Reprogramming Tumor-Associated Macrophages in PDAC with MicroRNA Nano-Vectors
|
5R21CA213114-02
|
$217,282
|
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-05
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Role of Splicing Factors in Breast Cancer
|
5R00CA178206-05
|
$249,000
|
|
ANCZUKOW-CAMARDA, OLGA
|
JACKSON LABORATORY
|
|
Sensitization to CD47 Blockade to Enhance Anti-Tumor Immunity
|
5F30CA195973-04
|
$49,524
|
|
ANDERSON, KATIE
|
UNIVERSITY OF MINNESOTA
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-26
|
$301,545
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-06
|
$2,840,966
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Protease activated receptor-2 (PAR-2) signaling and metastatic ovarian cancer
|
5R01CA196988-02
|
$353,419
|
|
ANTALIS, TONI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Quantitative MRI Radiomics of Breast Cancer in Assessment of Malignancy and Response to Therapy
|
1F31CA221193-01A1
|
$26,048
|
|
ANTROPOVA, NATALIA
|
UNIVERSITY OF CHICAGO
|
|
Mutant BRAF-regulated transcription factors in melanoma progression
|
5R01CA196278-04
|
$356,850
|
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Design of Antiviral Drugs Effective Against the HIV-1 Virus
|
ZIA BC 009101
|
$161,564
|
$80,782
|
Appella, Ettore
|
CCR (NCI)
|
|
Elucidating transcription regulation by epigenetics in neuroblastoma
|
1K08CA226237-01
|
$206,394
|
|
APPLEBAUM, MARK
|
UNIVERSITY OF CHICAGO
|
|
A Novel Values-based Intervention to Increase Endocrine Therapy Adherence among Breast Cancer Survivors
|
1R21CA218723-01A1
|
$207,450
|
|
ARCH, JOANNA
|
UNIVERSITY OF COLORADO
|
|
Reducing risk of Anthracycline-related heart failure after childhood cancer
|
5R01CA196854-04
|
$604,525
|
|
ARMENIAN, SARO
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cerenkov imaging for in vivo pH determination of the tumor microenvironment
|
5F31CA206453-03
|
$31,442
|
|
ARROYO PACHECO, ALEJANDRO
|
UNIVERSITY OF PENNSYLVANIA
|
|
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
|
5R35CA197591-04
|
$977,640
|
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
The impact of e-cigarette use on adolescent uptake and persistence of conventional smoking: Who is most vulnerable?
|
5R01CA202262-03
|
$621,365
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Behavioral Activation for Smoking Cessation and the Prevention of Post-Cessation Weight Gain
|
5R01CA206058-03
|
$634,518
|
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
|
ZIA BC 010997
|
$85,103
|
$2,553
|
Avital, Itzhak
|
CCR (NCI)
|
|
Bone Marrow Stem Cells Participation in Solid Organ Cancers Carcinogenesis
|
ZIA BC 011004
|
$255,308
|
$2,553
|
Avital, Itzhak
|
CCR (NCI)
|
|
Development of a New Generation Micro-CT imaging for Functional and Molecular Imaging of Cancer
|
5R01CA196667-04
|
$521,837
|
$521,837
|
BADEA, CRISTIAN
|
DUKE UNIVERSITY
|
|
The contribution of the innate immune sensor STING in GVHD and GVL following allogeneic hematopoietic stem cell transplantation
|
1F31CA216999-01A1
|
$44,524
|
|
BADER, CAMERON
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Post-chemotherapy Symptom Management: Testing Intervention Sequences in a SMART Design
|
1R01CA225615-01
|
$632,908
|
|
BADGER, TERRY
|
UNIVERSITY OF ARIZONA
|
|
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
|
5R01CA155769-07
|
$410,877
|
|
BADIE, BEHNAM
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Obesity-driven Metabolic and Molecular Biomarkers of Metformin Response in Endometrial Cancer
|
1R37CA226969-01
|
$355,706
|
|
BAE-JUMP, VICTORIA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
Total relevant funding to Sarcoma for this search: $67,580,000
|